Trademark Overview
On Wednesday, May 6, 2026, a trademark application was filed for ENNUMO with the United States Patent and Trademark Office. The USPTO has given the ENNUMO trademark a serial number of 99806285. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, May 6, 2026. This trademark is owned by Accord Biopharma, Inc.. The ENNUMO trademark is filed in the Pharmaceutical Products category with the following description:
Therapeutic pharmaceutical for the treatment of of cancer and cancer-related
comorbidities; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for stimulating white blood cell
production; Pharmaceutical preparations for use in
oncology; Pharmaceutical preparations for the treatment of of cancer and cancer-related comorbidities